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Giving Patients
A Second Chance

The Best Physicians in St. Loui
n the fields of nuclear medicine, radiation oncology, and
radiology, Mallinckrodt Institute physicians swept the field
-of "Best Doctors in St. Louis," as reported in the August
2002 issue of St. Louis Magazine. The list of 441 doctors in
37 specialties was compiled by Best Doctors, Inc., a research
and information company that maintains The Best Doctors in
America database of approximately 30,000 doctors in more
than 40 medical specialties. Best Doctors polls thousands of
physicians worldwide, asking for nominations to the list based
on patient care rather than academic excellence or research.

Nuclear Medicine
Farrokh Dehdashti, MD
Keith Fischer, MD
Robert Gropler, MD
Tom Miller, MD, PhD
Mark Mintun, MD
Henry Royal, MD
Barry Siegel, MD

Radiation Oncology
Perry Grigsby, MD
JeffMichalski, MD
Robert Myerson, MD, PhD
Joseph Simpson, MD, PhD
Marie Taylor, MD
Todd Wasserman, MD

Radiology
Claire Anderson, MD
DeWitte Cross, MD
Michael Darcy, MD
Jay Heiken, MD
David Hovsepian, MD
William McAlister, MD
William Middleton, MD
Barbara Monsees, MD
Christopher Moran, MD
Daniel Picus, MD
David Rubin, MD
Stuart Sagel, MD
Marilyn Siegel, MD
William Totty, MD
Thomas Vesely, MD
Franz Wippold, MD
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THE WASSERMAN SYMPOSIUM

The "Current Topics in Cancer Treatment"
symposium honored Dr. Todd Wasserman for his
outstanding clinical, academic, and research
contributions to the field of radiation oncology.

GIVING PATIENTS A SECOND CHANCE

Two nonsurgical vascular procedures—
chemoembolization and radiofrequency
ablation—combined with the expertise of
Mallinckrodt Institute's interventional
radiologists provide a comprehensive approach
to liver cancer therapy for critically ill patients.

COMMUNITY-HOSPITAL RADIOLOGY SERVICES

The partnership of Mallinckrodt Institute and
Barnes-Jewish West County Hospital offers
excellent patient care, leading-edge technology,
and the convenience of a community hospital.
THE CLINICAL PET CENTER

With more than a century of collective experience
in nuclear medicine and positron emission
tomography, the physicians of the Clinical PET
Center now have the added advantage of the area's
only PET/CT scanner to aid in the detection and
localization of disease.
A SON'S TRIBUTE

The pink granite monolith that rests in the atrium
of the Eric P. Newman Education Center was
lovingly created by artist Ian Gilula as a lasting
tribute to his father, Dr. Louis Gilula.

ON THE COVER Daniel Brown, MD, performs a targeted treatment called radiofrequency
ablation that destroys liver tumor cells with less tissue destruction. Photograph by Tim Parker.
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McAlister
named Teacher
of the Year

34th Annual
Wilson Award
presented

This year the senior
diagnostic radiology residents elected William
McAlister, MD, chief of
pediatric radiology and radiologist-in-chief at St. Louis
Childrens Hospital (SLCH),
as the Mallinckrodt Institute
faculty member who made
the most outstanding
contributions to resident
education through course
study, conferences, and
clinical activities. The presentation was made in June
at the annual farewell dinner
for residents and fellows,
which is sponsored by
Eastman Kodak Company.
McAlister was named
chief of pediatric radiology
in 1965 and professor of
radiology and of pediatrics
in 1968. He also serves as
consulting radiologist for
Shriners Hospitals for
Children, St. Louis.
In addition to an active
clinical practice, he is
involved in ongoing research
of metabolic bone disease
and skeletal dysplasia with
Michael Whyte, MD, at
Shriners Hospital.
McAlister's seminal research
on the adverse effects of
tannic acid on the liver
prompted the FDA to ban
the use of tannic acid in barium enemas. His NIH-funded
research focused on the
microvascularity of transplanted tumors in mice, the

In recognition of his
outstanding work in basic
radiological sciences, ShaoPow Lin received the Hugh
M. Wilson Award for Meritorious Work in Radiology. The
award is presented in honor
of Doctor Hugh Wilson,
Mallinckrodt Institute's second director and an advocate of the advancement of
education.
Under the mentorship of
Jeffrey Neil, MD, PhD, associate professor of neurology,
of pediatrics, and of radiology, Lin, who received a
medical degree and a doctoral degree in May, worked
on several research projects
in MIR's neuroimaging laboratory. According to Neil,
Lin's strong background in
electrical engineering
"enabled him to quickly
learn the nuances of RF coil
design for magnetic resonance experiments." Lin
designed and constructed
two devices that are now
being used in the neuroimaging lab: a transmit/receive
coil (which Neil says is
equivalent to those coils
available commercially) an>!
a power supply that interfaces with the MR spectrometer console.
After completing an
internship at a St. Louis ho
pital, Lin will return to
Mallinckrodt Institute to jo n
the Research Residency
Program.

histologic effects of contrast
media and ways to modify
those effects, and alterations
of the microvascularity in
experimental renal vein
obstruction.
He has served on the
SLCH Clinical Management
Committee since 1993 and
the American College of

Radiology's (ACR's)
Committees on Standards
and Appropriateness since
1994. McAlister is a fellow of
the ACR and a diplomate of
the. American Board of
Radiology. He is past
president of the Society for
Pediatric Radiology (SPR),
past chairman of the SPR
Board of Directors, and the
1998 recipient of the SPR
Gold Medal Award.
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Ruhrwien
named to
[WHO'S WHO
Laura Ruhrwien, director of information systems
for Mallinckrodt Institute,
was inducted into the
WHO'S WHO Historical
Society. She will be listed in
the 2002-2003 edition of
International WHO'S WHO
of Information Technology,
one of a series of highly
selective and prestigious
international reference
books published by the
North Carolina-based Gibralter Publishing, Inc.
Ruhrwien joined the
staff of MIR in 1997. She previously worked in the corporate sector as a senior
manager at Ernst & Young, a
global financial services
corporation.
The History Society,
which has been documenting multi-indexed unabbreviated biographies of
successful individuals
since 1928, provides an
international forum for
networking and reference.
More than 90,000 members
in 150 countries comprise
this professional organization.

Jost appointed
to ARR, joins
IS3R
Gilbert Jost, MD, professor of radiology and director
of Mallinckrodt Institute,
was appointed to the Executive Committee of the Academy of Radiology Research
Board of Directors. In 2000,
the Academy was instrumental in creating a milestone
for radiology and the imaging sciences: the National
Institute of Biomedical Imaging and Bioengineering
(NIBIB), the newest of the
National Institutes of Health
research institutes and centers. The NIBIB will create
opportunities for research
that accelerates the development of new imaging tech-

niques and technologies
with clinical and research
applications.
Jost was invited to join
the prestigious International
Society for Strategic Studies
in Radiology (IS'R). The
22-member society "serves
as a marketplace for the
exchange of ideas and experience and has brought
together the most renowned
experts [in radiology practice and research] in the
world." The biannual IS'R
meetings focus on challenges to radiologists worldwide, current trends in
radiology, future developments in radiological sciences, and collaboration
with leading industrial
companies.

The clinical faculty of
the Department of Radiation
Oncology appointed Robert
Malyapa, MD, PhD, as the
2002-2003 radiation oncology
chief resident and Angel
Blanco, MD, as assistant
chief resident. Malyapa
received an undergraduate
degree from Loyola University, India, and a medical
degree from the Jawaharlal
Institute for Postgraduate
Medical Research. Blanco
received an undergraduate
degree from Emory University and a medical degree
from Baylor College of
Medicine.

At the residents and fellows farewell
dinner in June, Gilbert Jost, MD,
director of the Institute, (right)
congratulated Gary Shackelford, MD,
professor of radiology and of
pediatrics, on being named emeritus
professor of radiology.

"*

■■-

=- -^B
'

FOCAL SPOT, SUMMER 2002

Chief
residents
appointed

CURRENT TOPICS IN CANCER TREATMENT

A symposium was held on July 12 to honor
Todd Wasserman, MD, professor of
radiation oncology, for his outstanding
contributions to the field of radiation
oncology and for his many years of
service to the Department of Radiation
Oncology,

Mallinckrodt

Institute,

Washington University, and, especially, his
patients. The invited speakers, who
represented some of the nation's top cancer
centers, shared their clinical and research
expertise in the treatment of cancer.
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Symposium attendees gathered in the Eric P. Newman Education
Center at Washington University Medical Center to hear Charlotte
Jacobs, MD, speak on "Todd Wasserman's achievements."

At the dinner following the symposium, Amy
and Derek Wasserman shared some amusing
anecdotes about their father and expressed
their pride in his accomplishments.

•

•

>
At the close of the symposium,

: Wasserman (seated) received a standing
ation from symposium attendees and speakers,
nding directly behind Wasserman is James
y, PhD, professor of radiation oncology and
ief of the Department of Radiation Oncology's
^ivision of Physics.

Carlos Perez, MD, chairman of

Jeff Michalski, MD, associate

the Department of Radiation

professor of radiation oncology

David Brizel, MD, spoke on

Oncology, invited symposium

and chief of the Clinical Division

"Radioprotectors in oncology."

guests to a reception and tour of

of Washington University's

the new radiation oncology facili-

Department of Radiation

ties in the Alvin J. Siteman Cancer

Oncology.

Center on the lower level of the
Center for Advanced Medicine.
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SYMPOSIUM FACULTY
CARLOS PEREZ,

MD, SYMPOSIUM CHAIRMAN

Professor and Chairman
Department of Radiation Oncology
Washington University
St. Louis, Missouri
DAVID BRIZEL,

MD, PROFESSOR

Department of Radiation Oncology
At the dinner following the symposium,

Duke University Medical Center

Donald Chapman, PhD, from Fox Chase

Durham, North Carolina

Cancer Center in Philadelphia, presented a
During the afternoon break, symposium speakers continued

copy of the poem he wrote in honor of his

their discussions of advances in cancer treatment:

long-time friend Todd Wasserman. Seated,

MD, DEPUTY DIRECTOR

NORMAN COLEMAN,

(left to right) Timothy Eberlein, MD; Norman Coleman, MD;

to the right of Wasserman, is Mark

Division of Clinical Sciences

and Walter Curran, MD.

Wrighton, PhD, chancellor of Washington

National Institutes of Health/National Cancer

University in St. Louis.

Center
Bethesda, Maryland
JAMES COX,

MD, CHAIRMAN

Department of Radiation Oncology
M. D. Anderson Cancer Center
Houston, Texas

THE WASSERMAN SYMPOSIUM
WALTER CURRAN,

MD, CHAIRMAN

Department of Radiation Oncology
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania
TIMOTHY EBERLEIN,

CURRENT TOPICS
IN CANCER TREATMENT

MD, DIRECTOR

Alvin J. Siteman Cancer Center
Washington University Medical Center
St. Louis, Missouri

x

,* v

CHARLOTTE JACOBS,

£

MD, DIRECTOR

Clinical Cancer Center
Stanford University Medical Center
Stanford, California
THEODORE PHILLIPS,

MD

Department of Radiation Oncology
University of California
San Francisco, California

(Left to right) Doctors Curran, Cox, Perez,
Jacobs, Wasserman, Phillips, and Coleman.

giving pane
a see munmu
Interventional radiologists use
two nonsurgical procedures
to destroy tumors in the liver.

by Barbra Rodriguez

Brown (foreground) and

rteries wend their way throughout the body, where

Noah Appel, MD, clinical
fellow in interventional

they serve as crucial pipelines for bringing nutrients

radiology, consult during an
RF ablation procedure.

and oxygen to energy-starved tissues. Yet these same vessels
can serve a deadlier purpose by nourishing tumors that lie
deep within the body, making them difficult to detect.
This difficulty means tumors in the liver and certain
other internal organs often cannot be identified until they
are too big or too numerous to remove surgically. In recent
years, though, several patients with liver cancer have been
given a second chance at life as a result of Mallinckrodt
Institute interventional radiologists' use of arteries as portals
for delivering anti-tumor treatments.

1

a second ctiance

"Many patients who come to us
for a consultation do not expect to
live very long," says Daniel Brown,
MD, assistant professor of radiology and of surgery. "Our interventional procedures are a real eye
opener for these patients."
Brown treats patients from all
parts of the United States who
need targeted treatments that leave
most of the liver intact. Many
patients are likely to need repeated
treatments because they are prone
to developing new primary hepatocellular carcinomas (HCC) or
recurrent liver metastases that
result from gastrointestinal carcinoid tumors or other hormoneproducing tumors.
The patients benefit from a
nonsurgical vascular approach for
destroying tumors called
chemoembolization or from a more
targeted treatment called radiofrequency (RF) ablation that
destroys tumor cells with currentinduced heat. Neither approach
radically alters nearby liver tissue,
so the procedure can be repeated if
necessary or can be used sequentially to the same patient.
Michael Darcy, MD, professor
of radiology and of surgery and
chief of Mallinckrodt Institute of
Radiology's (MIR's) interventional
radiology section, began performing chemoembolization for liver
cancer in 1993. Brown joined the
MIR faculty in 1999, with extensive
experience in liver tumor
management.
"We are the only interventional
radiology group in the St. Louis
area that offers a comprehensive
approach to cancer therapy using
both vascular and nonvascular
intervention," Darcy says, noting
that patients receive the most suitable approach as a result.

chemoembolization
With chemoembolization, a
catheter is placed into the patient's
femoral artery. From there, the
catheter is selectively advanced
into the hepatic artery, which is the
main blood supply for the liver. A
liquid contrast agent is injected
into the catheter to determine how
the blood vessels fan out into the
liver tissue. The interventional radiologist then injects a mixture of
drugs and embolic agents.
An oily substance called Ethidiol, which is mixed with three
chemotherapeutic drugs, is
injected and collects in the cancerous tissue. Because these drugs are
injected directly into the tumor
site, the tumor is exposed to much
higher doses than could be
achieved via a peripheral infusion.
Flow into the tumor bed is
obstructed with polyvinyl alcohol
(PVA) particles. The combination
of PVA and Ethiodol trap the high
doses of chemotherapy in the liver,
preventing systemic effects.
Researchers have found that Ethidiol can help lock drugs within the
liver for up to a month following
chemoembolization.
Healthy liver tissue survives
because another vessel, the portal
vein, supplies blood to much of the
organ. "You can kill the tumor without harming normal liver tissue,
and the portal vein will take over
the function that the hepatic artery
can no longer do," Brown says.
Approximately 60 percent of
patients have the classic arrangement of blood vessels feeding the
liver, as described in most medical
texts. The treating physician must

Michael Darcy, MD

be acutely aware of any variation in
a patient to prevent adverse outcomes. In particular, a physician
must block the hepatic artery past
a vessel that branches off to feed
the bowel. Otherwise, the lack of
blood flow combined with highdose chemotherapy to that organ
creates severe ulcers.
Another issue is that patients
with HCC have cirrhosis, a chronic
liver disease that is often a result of
alcohol abuse or exposure to other
toxic chemicals. Many patients
develop cirrhosis from viral hepatitis type C or other infection.
Regardless of the cause, the liver,
which functions in part to process
toxic chemicals, becomes overwhelmed by the insult and tries to
repair itself by bumping up its rate
of cell division.
That rapid cell division
increases the risk of some cells
becoming the abnormal, cancerous
cells of HCC. And it produces scar
tissue that replaces functional tissue involved in maintaining the
body's metabolism, blood pressure,
and other functions. The cirrhosis

MALLINCKRODT INSTITUTE OF RADIOLOGY
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CHEMOEMBOLIZATION
Case 1

r
leads to tumor development while
it limits treatment options, as the
remaining liver is severely diseased. Therefore, patients with
HCC and cirrhosis are more at risk
of dying if a medical procedure
reduces remaining liver function
too drastically. Less than 20% of
patients are candidates for surgery.
Although the interventional radiologists at Mallinckrodt Institute
have had great success with liver
ablative techniques, patients must
be carefully chosen to avoid treating those patients with an inadequate reserve of liver function.
Brown and Darcy have been
successful with chemoembolization and other procedures because
of their careful selection of patients
and their expertise with the techniques. Because of their large volume of referred patients, Brown
and Darcy have a better understanding of the boundaries of treatment than do physicians at many
medical centers. "We've treated
patients at Mallinckrodt Institute
that other hospitals have turned
away," Brown says.
Under Brown's care, patients
with HCC have lived an average of
20 months after diagnosis. Brown,
who leads workshops on vascular
and interventional oncology for the
Society of Interventional Radiology, notes that studies relying on
peripheral chemotherapy or supportive management have reported
an average survival of only three
months.
Patients who receive
chemoembolization at Mallinckrodt
Institute also benefit from staying
only one or two days in the hospital, as compared to the week or so
required for traditional surgery.

a. There is an enhancing 10 cm hepatocellular carcinoma in the left lobe of the liver.
b. Arteriography prior to embolization demonstrates the abnormal vessels.
c. Follow-up CT after chemoembolization demonstrates complete tumor necrosis.

a. Unenhanced CT demonstrates numerous large tumors in a patient with carcinoid syndrome.
He was experiencing diarrhea several times a day as well as hot flashes,
b and c. Early and late phase of angiography reveals the marked hypervascularity of the tumors,
d. Following embolization the patient's symptoms resolved.

RADIOFREQUENCY ABLATION
Case 1

a. Hypervascular hepatocellular carcinoma of the right lobe of the liver.
b. The RFA needle is deployed within the tumor.
c. Following RFA the lesion no longer enhances. Normal inflammatory response is
identified surrounding the dead tumor.

Case 2

a. 4 cm hepatocellular carcinoma in the right lobe of the liver with nearby bowel
b. Following RFA with careful needle placement, the tumor no longer enhances
and the bowel is uninjured.
Case 3

a. This patient has a single metastasis to her liver after resection of breast
carcinoma. She was not a surgical candidate for liver resection.
b. Following RFA the entire area surrounding the tumor is necrotic.

FOCAL SPOT, SUMMER 2002
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And patients avoid not only the
weeks of treatment required for
traditional chemotherapy but also
chemotherapy's potential adverse
effects, such as hair loss and weakened immune system function.

Needle electrode (shown with prongs extended)
used in radiofrequency ablation of liver tumors.

10

radiofrequency ablation
Brown also performs the RF
ablations for liver cancer done at
MIR. To qualify for this high-tech
procedure, a patient must have
three or fewer
tumors that are
less than 4 centimeters in size.
The RF approach
is favored under
these circumstances because it
produces less tissue destruction
and takes less
time than does
chemoembolization.
Using ultrasound guidance,
the radiologist
inserts a needle
electrode through
a small incision in
the skin and
directly into the
liver tumor. He
then pushes a
plunger to eject a
series of prongs
from the needle's
tip that fan out
like an umbrella
frame. Current is
sent into the tines
and incites ions in
tumor cells
nearby to follow
the flow of current. "The current
creates friction,
similar to rubbing
your hands
together," Brown
says.
Friction, in
turn, creates heat. When the temperature inside the tumor cells surpasses 50° Celsius, the cells begin
to die. A much higher temperature

— about 75° Celsius, or roughly
167° Fahrenheit — is reached during RF ablation. The procedure
takes about an hour, and patients
can go home the same day.

a new lease on life
Best of all, some patients with
HCC whose tumor burden is kept
in check by chemoembolization
and RF ablation may gain a new
lease on life as a result. Eligible
patients with HCC can remain on a
liver transplantation list if they
have a single tumor that is kept
below 5 centimeters (about 2
inches) in diameter or three tumors
less than 3 centimeters in diameter.
An example of this type of
patient is Robert Brewer, a 59-yearold St. Louis County resident. He
received two courses of chemoembolization and an RF ablation treatment and has remained on the
transplantation list for 15 months.
Diagnosed with hepatitis C in 1999,
Brewer still suffers from joint
aches and exhaustion but is kept
going by his wife of 38 years, three
children, and three grandchildren.
Knowing that he might receive a
liver transplant also keeps him
motivated. "That's what it takes for
me to live," Brewer says.
Brown's and Darcy's ministrations have resulted in 13 patients
with HCC taking the next step and
receiving liver transplants in the
past 3 years. But the benefits are
not just for these patients. Those
patients who have neuroendocrine
tumors or other hormonally linked
tumors such as insulinomas also
benefit. In the case of gastrointestinal carcinoid tumors, patients may

MALLINCKRODT INSTITUTE OF RADIOLOGY
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live 5 years to 10 years after
diagnosis, thanks in part to the
repeated removal of liver
metastases.
The problem is not the carcinoid liver tumors themselves but
what these tumors produce: hormones such as serotonin that the
liver can no longer degrade when
its tumor burden becomes overwhelming. As a result, excess levels
of hormone remain in the bloodstream, causing symptoms such as
facial flushing and recurring bouts
of diarrhea.
By eliminating the liver tumors,
Brown can keep the patient's symptoms in check for a year or more
until additional tumors crop up.
"We can help patients take back
some control and feel normal again
— feel good about themselves,"
Brown says.

additional studies
Brown also is collaborating
with Louis Gilula, MD, professor of
radiology and of surgery and a
member of MIR's musculoskeletal
radiology section, to test RF ablation's usefulness in treating bone
cancer. As participants in a multicenter trial sponsored by the American College of Radiology Imaging
Network, Brown and Gilula are
participating in a Phase II trial to
determine whether RF ablation
provides a good alternative to radiation therapy for treating bone
metastases in non-weight-bearing
bones and the spine. The limited
invasiveness of RF ablation and its
ability to provide relief with a single treatment session may make it
a better option for the long-term
management of bone metastases.
Just as with the patients
treated by Brown and Darcy, these
patients will have routine checkups
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that involve radiological imaging to
detect additional or remaining cancerous growths. Building long-term
relationships with patients and
their families is thus an important
facet of what the physicians do.
Brown notes that this relationship
is also one of his most rewarding
responsibilities.
He says that keeping a patient's
needs uppermost in his mind is an
important facet of this process—
that is why he uses RF ablation
rather than an alternative version
that can require four or more hospital visits to complete treatment.
And he talks with the patient's family by phone whenever possible, so
they do not have to make extra
trips for consultation. And it is why
he spends as much time as is necessary with patients to discuss
their medical status, something
Robert Brewer says he admires
about Brown. "He's the kind of doctor who will sit down and talk with
you and explain exactly what you
need to do," Brewer says.
Brown also includes humor to
lighten conversations with families,
who use the humor as a way of
coping. For example, Brown often
refers to the annual embolization in
patients with slow-growing gastrointestinal carcinoid tumors as
the patients' "once a year tune-up,"
like the one they get for their car.
Along with Joel Picus, MD,
associate professor of medicine,
Brown is studying the use of magnets to help attract chemotherapeutic agents to the liver. The
drugs are attached to ferromag-

netic particles that will be drawn
into the liver by a magnet placed on
a patient's abdomen, above the
tumor.
Brown also is involved with
pilot research evaluating chemoinfusion for treating pulmonary
metastases that are too advanced
for traditional surgery to be effective. The drug of choice, cisplatin,
can produce kidney damage before
clinical benefit is identified. And he
is performing lab studies to determine whether infusing high-dose
cisplatin into the pulmonary artery
through a balloon catheter is a better option. A chemical injected
intravenously soaks up much of the
leaked cisplatin and protects the
kidneys.
"The technique we use dramatically increases the level of
chemotherapy in the pulmonary tissues," says Brown, who plans further studies after promising initial
results.
Equally rewarding to Brown
are the relationships he has with
colleagues from other medical
groups and at Mallinckrodt Institute, from secretarial staff to
research assistants to faculty, who
play an integral role in diagnosing
and treating oncology patients.
"Without the referrals from my colleagues in hepatology, oncology,
and hepatobiliary surgery, I would
not be able to help nearly as many
patients. Additionally, if I have a
radiology question, I can ask the
country's most renowned experts,"
Brown says, "whether it is interventional radiology, ultrasound, body
imaging, or any of the other radiology specialties. They are all here at
Mallinckrodt Institute." EH3

community-hospital
RADIOLOGY SERVICES
Mallinckrodt Institute of Radiology at
Barnes-Jewish West County Hospital
combines quality service with easy
access for patients.

by Chris Wayland

"JL l.\_x
From weekend warriors to couch potatoes to professional and student athletes, all types of
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The radiologists on staff at BJWCH are
Washington University physicians who are

patients come through Mallinckrodt Institute of Radiology's (MIR's) Diagnostic Radiology
Department at Barnes-Jewish West County Hospital (BJWCH). The hospital is noted for excel-

faculty members of the world-renowned
Mallinckrodt Institute of Radiology.
• Joanna Costello specializes in magnetic

lence in orthopedics, especially sports medicine, physical rehabilitation, total joint replacement
surgery, and spine surgery. The high level of patient service combined with the convenience of a

resonance and orthopedics.
• William James, Mary Middleton,
and Levitt are general diagnostic

community hospital and accessible parking is a top draw for patients. That good reputation
resulted in the more than 53,000 radiology-related procedures performed last year.

According to Robert Levitt,
MD, director of diagnostic radiology at BJWCH, patient services
fall into three main categories:
outpatient diagnostics, outpatient
therapeutics and outpatient/
short-stay surgeries.
In the short-stay surgery
category, sports injuries and degenerative joint and spine disease
result in many hospital admissions
for surgical repair or replacement
of joints or spinal surgery, but the
hospital performs a host of other
specialized surgeries including
cosmetic, eye, general, and urologic surgery.
"Many patients, with the recommendation of their physicians,
are opting for outpatient surgeries,"
says Levitt. "Our hospital staff
includes Washington University
surgeons as well as surgeons in
private practice, such as the
physicians at Missouri Bone and
Joint and The Orthopedic Center of
St. Louis. All of these groups have
offices on the hospital campus."
And technology keeps the pace
moving briskly. "We have the 'latest
and greatest' of radiological equipment," Levitt notes.
Left: One control room serves both magnetic resonance
imaging (MRI) and computed tomography (CT).
Tracy Land, RT, a medical imaging technologist, is
shown in the CT area. The opposite side of the room
accommodates MRI.
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Radiology services include
magnetic resonance imaging (MRI),
bone densitometry, computed
tomography (CT), ultrasound, and
mammography. Fluoroscopic
rooms are available for barium
studies and special procedures,
such as MR arthrography (injecting
a substance into a joint space,
which outlines that area on MR
images). Nuclear radiology is also
available, including bone scans to
test for metastatic disease in
patients with cancer, thyroid scans
to check for nodules, myocardial
scans to evaluate coronary artery
disease, hepatobiliary imaging to
assess gallbladder
function, and lung
scans to check for
pulmonary emboli.
The volume of
tests translates into
thousands of radiology reports to
physicians monthly.
Technological
advances have
decreased the time
required by doctors
to prepare the
reports and has made
report transmission
easier and faster.
Voice-recognition
dictation systems type out the
report as the physician speaks. A
signed report that once took hours

w%W%l!lll I IwllJ

radiologists.
• Alan Williams, a neuroradiologist in the
neuroradiology section at MIR, and
David Rubin, William Totty, and William
Reinus, all of the musculoskeletal
section at MIR, provide on-site specialty
interpretations at BJWCH.
According to Levitt, the combination of
generalists and subspecialists in the
radiology department at BJWCH is key to
delivering the high level of professional
services expected by referring physicians.
"It is that combination that explains
the success of our radiology
at BJWCH," he says.

William James, MD, instructor in radiology, dictates a
case, using the voice-recognition system.

HMflMBI^II^HHH^^HHII^HHIH

to complete now can be
done in five minutes,
Levitt says.
Patient care is
enhanced by the use of
a Picture Archiving and
Communication System
(PACS). Many of the
tests, such as nuclear
medicine, CT, ultrasound, and MRI can be
transmitted electronically among hospitals in
the BJC HealthCare™
system as well as physician offices.
"PACS is a series of computers
designed to store and display diagnostic images," explains David
Melson, MIR's manager of imaging
applications. "By providing on-line
access to both current and prior
studies, PACS enables the radiology department to work more
efficiently. Referring physicians
will also have access to the images
electronically, using a BJC applica-

The Imaging Center offers easy access for all patients.

[easy

tion called Clinical Desktop that
links the referring physician's
computers to an MIR image server.
These factors lead to better service
for referring physicians and,
ultimately, better patient care".
Using teleradiology, MIR
radiologists at BJWCH can interpret imaging studies 24 hours a
day, seven days a week. The
images can be sent electronically
to a radiologist's home computer
or laptop. After interpreting the
image, the radiologist then
telephones the
interpretation to
the referring
physician.
Levitt is
particularly
proud of The
BJWCH Imaging
Center (at 969
Mason Road,
across the
street from the
hospital) that
opened in October 2001. It is
equipped with leading-edge technology, including a state-of-the-art
spiral CT scanner with 3-D imaging
capabilities that can help detect
conditions such as coronary artery
disease through calcium scoring
and lung carcinoma by thin section

examination of the lung fields.
Magnetic resonance imaging,
plain film X rays, and ultrasound are
also available at the Imaging Center.
Many physicians have their offices
in the Imaging Center, which is also
equipped with a computerized reading room. When a patient comes to
the Imaging Center, physicians can
access the patient's previous test
results from Barnes-Jewish Hospital
(BJH) at Washington University
Medical Center, BJWCH, or the
Imaging Center by using PACS. The
radiologist can then view the past
and current tests and compare them
side-by-side on the computer monitor. The findings of the new test
are dictated into the voice-activated
typing system, and the report is
archived. Once the test is in the
PACS system, it can be read at
either BJH, BJWCH, or the
Imaging Center.
Other facilities on the BJWCH
campus include physicians' office
buildings (POBs): POB 1 houses
private practice and Washington
University-affiliated physicians in
the specialties of urology, cosmetic
surgery, allergy/immunology, pulmonary medicine, ophthalmology,
pain management, and dermatol-
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Far Left: Levitt (right) and Daniel Gaitan, MD, an
endocrinologist, review a current case.
Left Center: Joanna Costello, MD, instructor in
radiology, is shown in the MRI procedure area.
Left: Mary Middleton, MD, assistant professor of
radiology, reviews CT cases with David Johnston,
MD, a third-year diagnostic radiology resident.

ogy. POB 2 houses Missouri Bone
and Joint and The Orthopedic
Center of St. Louis, both privatepractice groups specializing in
orthopedic and spine surgery. In
POB 3 is The Heart Care Institute,
staffed by Washington University
cardiologists, and the Washington
University orthopedic and spine
surgery offices.
Due to the popularity of
BJWCH, the demand for operatingroom time has outstripped the
capacity of existing operating
rooms. An outpatient Ambulatory
Surgery Center, slated to open in
the spring of 2003, will double the
hospital's number of operating
rooms.
Levitt is proud of BJWCH and
the services MIR offers to the
hospital's patients. "We are able to
provide the expertise of an academic center in a community setting",
he says, and emphasizes that
everyone at BJWCH—administrators, Washington University
physicians, private physicians, and
hospital staff— have a common
goal: to provide the highest quality
clinical care in a compassionate
community-hospital setting. DEI

Levitt, who was named director of diagnostic radiology at BJWCH in 1990, meets with a patient who is
scheduled to undergo a lumbar spine series.
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A HISTORY OF. t

innovation AND
quality patient care
BY CANDACE O'CONNOR

The CT/PET scanner
allows physicians to
see both the function
and precise location
of a lesion in a single
study. Photo courtesy of Siemens Medical Solutions.

MOST PATIENTS LOOKING FOR HEALTH CARE
EXPECT TOP QUALITY CARE AND EXPERIENCED PHYSICIANS. THEY SHOULD EXPECT NO LESS
FROM A DIAGNOSTIC IMAGING FACILITY. AT THE
CLINICAL

PET

CENTER, PATIENTS HAVE THE

ADVANTAGE OF WASHINGTON UNIVERSITY
NUCLEAR MEDICINE PHYSICIANS, WHO ARE
AFFILIATED WITH THE WORLD-RENOWNED
MALLINCKRODT INSTITUTE OF RADIOLOGY (MIR)
AND THE TOP-RANKED BARNES-JEWISH HOSPITAL (BJH). THESE PHYSICIANS COLLECTIVELY
HAVE OVER 145 YEARS OF EXPERIENCE IN
NUCLEAR MEDICINE AND 50-PLUS YEARS IN
POSITRON EMISSION TOMOGRAPHY (PET) IMAGING.

I

MORE THAN

PET

2,400

COMPREHENSIVE DIAGNOSTIC

image interpretation better and the
data much easier to use."
For patients with cancer, that
will translate into even better care.
It is critically necessary for physicians to accurately localize lesions
in these patients, says Farrokh
Dehdashti, MD—but comparing
PET and CT images side-by-side
has never been as easy or as accurate as physicians would like. Now
the merged images supplied by the
PET/CT scanner will allow the
medical team to improve detection
and localization of disease and better direct biopsy or therapy.
"PET/CT scanners have been
shown to be twenty percent more
accurate for disease detection than
is PET imaging alone," says
Dehdashti, associate professor of
radiology. "The use of these scanners is expected to reduce the
number of invasive and noninvasive procedures in evaluating
patients with cancer."

EXAMINATIONS ARE PERFORMED ANNUALLY. AND

THIS COMBINATION TRANSLATES INTO A MORE
ACCURATE DIAGNOSIS AND A SMOOTHER PROCESS FOR THE

PATIENT AND THE REFERRING PHYSICIAN.

The Institute has been
a leader in PET technology since
the early 1970s, when a team of
MIR researchers, led by Michel TerPogossian, PhD, developed the first
useable PET device for human
studies. A broad PET research program followed. And in 1989, MIR
opened the first clinical PET facility in Missouri and one of the first
three in the United States. In 1992
BJH took over the technological
operations of the Clinical PET Center; MIR's Division of Nuclear Medicine continued to staff the facility.
In October 2002, the Clinical
PET Center will mark an exciting
new milestone: the arrival of the
first combined PET/CT (computed
tomography) scanner in the
FOCAL SPOT, SUMMER 2002

St. Louis metropolitan area.
Already, the Center has two
dedicated PET scanners that are
heavily used. But this new scanner,
which Time magazine called in
2000 "the invention of the year,"
represents a major technological
breakthrough.
"The Biograph" PET/CT scanner, which also incorporates a new
type of radiation detectors, will
offer a faster imaging time and
better images," says Barry Siegel,
MD, professor of radiology and of
medicine and director of the
Division of Nuclear Medicine. "It
will give us the ability to fuse
anatomical data from the CT scanner directly with metabolic data
from the PET scanner, making

Barry Siegel, MD

BURGEONING
CLINICAL USES

This new technology is bolstering a field in which the clinical
applications of PET, a tool that
17

THE CLINICAL PET CENTER

Farrokh Dehdashti, MD

assesses biochemical processes in
patients and produces functional
images of metabolic activity, have
steadily increased over the past
decade. With their first PET scanner—the Super PETT-IIB, built at
Washington University by TerPogossian in the mid-1980s for
research and later converted to
clinical use—Siegel and the nuclear
medicine team began by focusing
on images of the brain and heart.
But this early scanner only
allowed physicians to view the
metabolic activity in a limited area
of the body. Then new equipment
came on the market that provided
many imaging slices at once over a
larger area of the body. In 1991,
Siegel's group bought a scanner
from CTI, Inc., the ECAT EXACT.
MIR's nuclear medicine faculty, in
collaboration with CTI scientists,
developed practical techniques and
the necessary software for wholebody imaging.
These technological advancements allowed MIR's Division of
Nuclear Medicine to move into the
field of oncology; early work
involved scanning of soft-tissue
sarcomas, deciding whether a mass
18

was malignant, and identifying the
best place to biopsy. Lung-cancer
applications were developed, as
PET was used to distinguish benign
from malignant lung nodules and to
detect metastatic deposits.
"Over the years, PET has
slowly grown into a technique that
is used for diagnosis, staging,
restaging, and, most recently, treatment monitoring for a wide variety
of cancers," says Siegel, who currently chairs the Institute of Clinical PET Council of the Academy
for Molecular Imaging.
Today at Mallinckrodt Institute, PET is used clinically in many
forms of cancer: cervical, colorectal, esophageal, head and neck,
lung, malignant melanoma, lymphoma, and breast, especially
recurrent and distant metastatic
disease. Recently, in collaboration
with the University of Michigan and
Duke University, Siegel's group
completed a large clinical trial to
study the effectiveness of PET in
evaluating the axillary lymph nodes
of women with breast cancer.
"Particularly in the field
of oncology,
there are several research
studies unique
to our institution," says
Dehdashti,
"such as PET
imaging of
estrogen receptors in breast
cancer, androgen receptors in
prostate cancer,
and tumor
hypoxia and
multidrug resistance in a variety of cancers.
We are also involved in several
multicenter clinical trials, such as
those evaluating the uses of PET in
lung and esophageal cancers."

Historically, MIR's nuclear
medicine physicians have believed
so strongly in this research that
they have provided many of these
scans free-of-charge. Mallinckrodt
Institute and Barnes-Jewish Hospital have underwritten scans, and
continue to do so, when Medicare
or insurance companies refused to
cover them and patients could not
afford to pay. "We don't turn
patients down for appropriately
indicated studies," says Siegel.
INCREASING DEMAND
Over the past several years, the
eight-member nuclear medicine
team has seen its PET workload
increase dramatically. In 1989,
around 100 studies were performed
altogether; now the average is 10 to
12 per day. Patient totals have been
rising at a rate of 30 percent to 40
percent annually.
As other PET centers open in
the region, those physicians often
come to Mallinckrodt Institute for
training, because of MIR's reputation in this field. "We have been

The Siemens Biograph CT/PET scanner can
significantly reduce scan time and enhance cancer
treatment and detection. Photo courtesy of Siemens
Medical Solutions.
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working with PET for a long time,
and we devote a lot of time to it,"
Siegel says. "This experience and
dedication translates into highly
trained physicians and technologists who screen examinations
carefully, assuring that the PET
study we are going to do is sensible
and answers the question the referring physician is asking. We make
sure that we have anticipated every
possible problem."
The Clinical PET Center's two
existing PET units (the ECAT
EXACT and the more recently
acquired C-PET) are located on
MIR's seventh floor. When the
PET/CT scanner arrives, it will be
installed in the radiology area adjacent to the new Center for
Advanced Medicine and the Siteman Cancer Center. There are four
other PET scanners around the
medical center, all owned by Washington University and all used for
research: a scanner on the seventh
floor for cancer and cardiac studies; another in the neurological
intensive care unit for brain
research, often in cases of head
injury or stroke; a third, also for
brain studies, in the East Building;
and a fourth, a micro-PET scanner
for imaging laboratory rodents, in
the Clinical Sciences Research
Building.
MIR also owns three
cyclotrons—and that is a bonus for
the Institute's PET program. While
other PET centers must buy commercially marketed fluorodeoxyglucose (FDG), the main
radiopharmaceutical used in PET
studies, Siegel's group has FDG
prepared on campus.
USING PET IN CERVICAL
CANCER CASES
Perry Grigsby, MD, is one of
the physicians who refers patients
to the nuclear medicine group for
PET evaluation. Most of his practice involves gynecologic cancers,
especially cancer of the cervix.
FOCAL SPOT, SUMMER 2002

When these women come to him
for treatment, Grigsby must first
evaluate where the cancer is and
how far it has spread. Is it limited
to the cervix? Or has it moved into
the pelvic lymph nodes, para-aortic
lymph nodes, or other sites?
For the past four years, PET
has been used to make most of
these determinations. Before then,
the gynecologic oncology team
used other imaging tools, such as
CT. "PET has been advantageous
because it is better at showing the
tumor spread than are other modalities," says Grigsby, professor of
radiation oncology and of radiology. "It is fair to say that from one
quarter to one half of women with
cervical cancer have had their
treatments changed because of
PET. It has had a great impact."

oncologic communities are convinced that PET should be a generally available imaging tool for
problem-solving in patients with
cancer," says Siegel. "We will still
want to use MRI [magnetic resonance imaging] or CT for certain
things, but it is clear that, for initial
staging of most cancers, PET is better than CT and MR, and is the test
that should be used."
In the future, Mallinckrodt
Institute's PET program is likely to
continue expanding. Siegel is
already looking toward the next
generation of PET/CT scanners,
with a larger imaging field and different design. For patients, that will
mean a faster exam—perhaps 15
minutes or less, as compared to the
current 45 minutes to an hour. A

THE FUTURE

As Siegel sees it, PET has a
bright future. In the past, smallscale studies had already shown
that PET prevented some 10 percent to 15 percent of unnecessary
surgeries in patients with lung cancer. Now a larger, rigorously controlled study from the Netherlands
has indicated that those figures
may be too low—that PET is even
more effective than previously
thought.
PET has some limitations,
Siegel admits. It has limited application in prostate cancer, for example, and is not yet fully accurate in
determining whether a suspicious
breast mass is malignant. New
radiopharmaceutical "tracers" used
in PET scans, some of them in
development at Washington University, may open avenues for PET
in these areas. Meanwhile, Siegel
and others have also been active in
urging Medicare, which currently
pays for some PET exams, to cover
more kinds of studies.
But overall, there is no longer
any question as to PET's clinical
utility. "At this point, the PET and

Perry Grigsby, MD

new micro-PET scanner may also
be in the offing.
"PET is our premier metabolic
imaging tool, and the paradigm of
the coming era of molecular imaging," says Siegel. EH
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Ian Gilula is a soft-spoken, contemplative young man
whose hidden strength and passion is revealed in his artistic creations.
One of his most cherished works is housed in the Eric P. Newman
Education Center on the Washington University Medical Center campus.
The 800-pound monolith is a tribute to Ian's father, Dr. Louis Gilula,
professor of radiology and of surgery and a member of Mallinckrodt
Institute's musculoskeletal radiology section.
At the dedication on June 17—appropriately, the Monday following
Father's Day—William Peck, MD, executive vice chancellor for medical
affairs and dean of the School of Medicine, said that the pink granite
monolith makes a "strong statement, indicative of Louis Gilula and of
Washington University School of Medicine."
According to Ian, his monolith was inspired by the ancient Mayan stela,
an upright slab of stone with a low-relief carving found in or near temples
throughout the Yucatan Peninsula. Stelas served as storyboards for the
3,000-year-old Mayan civilization.
"Art is a language, an expression of life that eases the mind and comforts the soul, much in the way my father's compassionate care for his
patients comforted their bodies," Ian says.
He hopes this monolith, his stela, will be a modern-day storyboard, a
tribute to the work ethic, the compassion, and the dedication of his father,
Louis Gilula.

A SON'S TRIBUTE
ART IS A LANGUAGE,
AN EXPRESSION OF
LIFE THAT EASES THE
MIND AND COMFORTS
THE SOUL, MUCH IN
THE WAY MY FATHER'S

Molten glass, which was cast and created by
Dean William Peck (right) commended Dr. Louis Gilula for his

Ian Gilula at Alfred University School of Art

many contributions to the care of patients at Washington

and Design in New York, is infused into

University Medical Center.

carved spaces on the front of the monolith.

—

COMPASSIONATE
CARE FOR HIS
PATIENTS COMFORTED
THEIR BODIES.

In honor of Louis A. Gilula, M.
His years of service and many contributions to
Washington University School of Medicine.
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In this section, the names of employees who are full-time
faculty or staff or who have an appointment in the
Department of Radiology or Department of Radiation
Oncology are highlighted in boldface type.

CHANGE IN
STATUS
Gary Shackelford, MD,
professor of radiology and
of pediatrics, was appointed
emeritus professor of
radiology.

Richard Kronemer, MD,
instructor in radiology, was
promoted to assistant professor of radiology, Division
of Diagnostic Radiology,
Department of Radiology.

PROMOTIONS

Gary Luker, MD, instructor
in radiology, was promoted
to assistant professor of
radiology, Division of
Diagnostic Radiology,
Department of Radiology.

Sanjeev Bhalla, MD,
instructor in radiology, was
promoted to assistant professor of radiology, Division
of Diagnostic Radiology,
Department of Radiology.

Christine Menias, MD,
instructor in radiology, was
promoted to assistant professor of radiology, Division
of Diagnostic Radiology,
Department of Radiology.

Joanna Costello, MD,
instructor in radiology, was
promoted to assistant professor of radiology, Division
of Diagnostic Radiology,
Department of Radiology.
William James, MD,
instructor in radiology, was
promoted to assistant professor of radiology, Division
of Diagnostic Radiology,
Department of Radiology.

NEW FACULTY
Wenhua Chu, PhD,
research instructor in radiology, Division of Radiological
Sciences, Department of
Radiology.
Michael Gelbart, MD,
instructor in radiology,
Division of Diagnostic
Radiology, Department of
Radiology.
Richard Kraus, MD,
assistant professor of radiology, Division of Diagnostic
Radiology, Department of
Radiology.
Robert Mach, PhD, professor of radiology, Division of
Radiological Sciences,
Department of Radiology.
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Vamsidhar Narra, MD,
assistant professor of radiology, Division of Diagnostic
Radiology, Department of
Radiology.
Mehdi Poustchi-Amin, MD,
instructor in radiology,
Division of Diagnostic
Radiology, Department of
Radiology.
Zhude Tu, PhD, MD,
research instructor, Division
of Radiological Sciences,
Department of Radiology.
Pamela Woodard, MD,
assistant professor of radiology, Division of Diagnostic
Radiology, Department of
Radiology.

FIRST-YEAR
FELLOWS
Ajeet Gordhan, MD, clinical fellow in neuroradiology,
received an undergraduate
degree and a medical degree
from the University of
Witwatersrand. He completed an internship and a
residency at Saint Louis
University.
Steven Hong, MD, clinical
fellow in abdominal radiology, received an undergraduate degree from Yale
University and a medical
degree from Baylor College
of Medicine. He completed
an internship and a residency at Baylor College of
Medicine.

Robert Lesniak, MD,
clinical fellow in interventional radiology, received an
undergraduate degree from
St. Norbert College and a
medical degree from the
Medical College of
Wisconsin. He completed
an internship at St. Luke's
Medical Center and a residency at the Medical College
of Wisconsin.
Archie McGowan, MD,
clinical fellow in neuroradiology, received an undergraduate degree from the
University of Pennsylvania
and a medical degree from
Dartmouth. He completed an
internship at Mt. Auburn
Hospital and a residency at
Brigham and Women's
Hospital.
Jordan Page, DO, clinical
fellow in neuroradiology,
received an undergraduate
degree from the University
of Missouri at Kansas City
and a medical degree from
The University of Health
Sciences—College of
Osteopathic Medicine. He
completed an internship at
Capital Region Medical
Center and a residency at
the University of Missouri,
Kansas City.
Mandar Pattekar, MD,
clinical fellow in abdominal
radiology, received an
undergraduate degree from
the University of Iowa and a
medical degree from Krishn
Institute of Medical
Sciences. He completed an
internship and a residency a
William Beaumont Hospital
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Michael Rodriguez, MD,
clinical fellow in interventional radiology, received an
undergraduate degree and a
medical degree from the
University of South Florida.
He completed an internship
at the University of Texas,
Galveston, and a residency
at the University of Texas,
Houston.
Mehrdad Sehizadeh, MD,
clinical fellow in neuroradiology, received an undergraduate degree from the
Gifted Children Educational
Center and a medical degree
from Tehran University of
Medical Sciences. He
completed an internship at
Detroit Medical Center and
a residency at Henry Ford
Hospital.
Lina Sierra Sierra, MD,
clinical fellow in abdominal
radiology, received a medical degree from the
Universidad Pontificia
Bolivariana. She completed
an internship at Clinica
Leon XIII and a residency
at Instituto de Clencias de
la Salud.
Paula Slack, DO, clinical
fellow in breast imaging,
received an undergraduate
degree from Washington
State University and a
medical degree from Des
Moines University. She
completed an internship and
a general surgery residency
at Doctor's Hospital,
Columbus, and a diagnostic
radiology residency at
Botsford Hospital.
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Susannah Thurman, DO,
clinical fellow in breast
imaging, received an undergraduate degree from
Southwest Missouri State
University and a medical
degree from The University
of Health Sciences—College
of Osteopathic Medicine.
She completed an internship
and a residency at Doctors
Hospital.
John Yu, MD, clinical
fellow in abdominal radiology, received an undergraduate degree and a medical
degree from the University
of Ottawa. He completed an
internship at The Ottawa
Hospital

NEW RESIDENTS
Heather Byer, MD,
assistant in radiology, is a
second-year diagnostic
radiology resident. She
received an undergraduate
degree from the College of
William and Mary and a medical degree from Georgetown
University. Byer completed
an internship and one-year
of diagnostic radiology
training at Georgetown
University.
Timothy Smullen, MD,
assistant in radiology, is a
second-year diagnostic radiology resident. He received
an undergraduate degree
from Miami University,
Oxford, and a medical
degree from Ohio State
University. Smullen completed an internship at
Riverside Hospital and one
year of diagnostic radiology
training at Ohio State
University.

FIRST-YEAR
DIAGNOSTIC
RADIOLOGY
RESIDENTS
Scott Bolton, MD, assistant
in radiology, received an
undergraduate degree from
Auburn University and a
medical degree from Johns
Hopkins University School
of Medicine. He completed a
one-year internship at
Barnes-Jewish Hospital.
David Chang, MD, assistant
in radiology, received an
undergraduate degree from
Yale University and a medical degree from Stanford
University. He completed an
internship at Yale—New
Haven Hospital.
Wincha Chong, MD, assistant in radiology, received an
undergraduate degree from
Brown University and a medical degree from Washington
University in St. Louis. She
completed a transitional
residency program at the
University of Hawaii.
James Colonnello, MD,
assistant in radiology,
received an undergraduate
degree from the University
of California, Davis, and a
medical degree from Saint
Louis University. He
completed an internship at
Loyola University.

Ryan Cook, MD, assistant
in radiology, received an
undergraduate degree from
Brigham Young University
and a medical degree from
Saint Louis University. He
completed an internship at
St. Mary's Health Center.
Michelle Dorsey, MD,
assistant in radiology,
received an undergraduate
degree and a medical degree
from the University of
Wisconsin. She completed
an internship at St. Luke's
Medical Center.
Nelson Elkins, MD, assistant in radiology, received an
undergraduate degree from
the University of Texas,
Austin, and a medical degree
from Texas Tech University.
He completed an internship
at Presbyterian Hospital.
Sean Higginson, MD, assistant in radiology, received an
undergraduate degree from
Wilkes University and a medical degree from the Medical
College of Pennsylvania—
Hahnemann University. He
completed an internship at
Chestnut Hill Hospital.
Jason Kerr, MD, assistant
in radiology, received an
undergraduate degree from
Brigham Young University
and a medical degree from
the University of California,
San Francisco. He completed an internship at the
Mayo Clinic, Scottsdale.

23

FYI
FIRST-YEAR DIAGNOSTIC
RADIOLOGY RESIDENTS

NUCLEAR
MEDICINE
RESIDENTS

Continued from page 23
Yuliya Lakhman, MD,
assistant in radiology,
received an undergraduate
degree from New York
University and a medical
degree from Johns Hopkins
University. She completed
an internship at the
University of Washington.
Kevin Lee, MD, assistant in
radiology, received an
undergraduate degree from
Pomona College and a medical degree from Washington
University in St. Louis. He
completed an internship at
Barnes-Jewish Hospital.
Judy Liu, MD, assistant in
radiology, received an undergraduate degree from the
University of California,
Los Angeles, and a medical
degree from Washington
University in St. Louis. She
completed an internship at
Arrowhead Regional Medical
Center.
Ryan Murtagh, MD, assistant in radiology, received an
undergraduate degree and a
medical degree from the
University of South Florida.
He completed an internship
at Barnes-Jewish Hospital.
Ashesh Parikh, MD, assistant in radiology, received an
undergraduate degree and a
medical degree from
Northwestern University. He
completed an internship at
the University of California,
San Francisco.

Creed Rucker, MD, assistant in radiology, received an
undergraduate degree and a
medical degree from the
University of Arizona. He
completed one year of a
surgery residency at
Vanderbilt University.
Karun Sharma, MD, PhD,
assistant in radiology,
received an undergraduate
degree from the College of
William and Mary. He
received a medical and a
doctoral degree from the
Medical College of Virginia.
Sharma completed a twoyear internship at the
Medical College of Virginia.
Krishna Thirumala, MD,
assistant in radiology,
received an undergraduate
degree from Duke University
and a medical degree from
the University of Alabama.
He completed an internship
at Baptist Hospital.
Daniel Wessell, MD, PhD,
assistant in radiology,
received an undergraduate
degree and two masters
degrees from North Carolina
State University. He received
a medical degree and a
doctoral degree from the
University of North Carolina.
Wessell completed an
internship at Western
Pennsylvania Hospital.

Brock McDaniel, MD,
assistant in radiology,
received an undergraduate
degree from California State
Polytechnic University and
a medical degree from the
Medical College of
Wisconsin. He completed
an internship and a residency at the University of
New Mexico Health Sciences
Center.
Christian Schmitt, MD,
assistant in radiology,
received an undergraduate
degree from the University
of Missouri, Columbia, and a
medical degree from Saint
Louis University. He completed an internship at Saint
Louis University and a residency at the University of
South Florida.
Jayson St. Jacques, MD,
assistant in radiology,
received an undergraduate
degree from Boston
University and a medical
degree from the American
University of the Caribbean.
He completed an internship
at the Hospital of St. Raphael
and a residency at Hartford
Hospital.

FIRST-YEAR
RADIATION
ONCOLOGY
RESIDENTS
Lilie Lin, MD, assistant in
radiation oncology, received
an undergraduate degree
and a medical degree from
Washington University in
St. Louis.
Parag Jitendra Parikh, MD,
assistant in radiation oncology, received an undergraduate degree from Case
Western Reserve University
and a medical degree from
Washington University in
St. Louis.
Catherine Wu, MD, assistant in radiation oncology,
received an undergraduate
degree and a medical degree
from Washington University
in St. Louis.

JOINT
APPOINTMENTS
Randy Buckner, PhD,
associate professor of psychology and of anatomy and
neurobiology, was appointee!
associate professor of radio!
ogy, Division of Radiologica
Sciences, Department of
Radiology.
Perry Grigsby, MD, profe:
sor of radiation oncology,
was appointed professor ol
radiology, divisions of
Nuclear Medicine and
Radiological Sciences,
Department of Radiology.
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Samuel Achilefu, PhD,
associate professor of
radiology, as principal
lvestigator, received a
$454,938 grant from the U.S.
tepartment of Defense to
study "Optical imaging of
mammoglobin expression in
breast cancer." Coinvestigators are Timothy Fleming,
research associate professor of surgery; John
Schotland, MD, PhD, associate professor of electrical
engineering and assistant
professor of radiology; and
Carolyn Anderson, PhD,
associate professor of radiology. As principal investigator, Achilefu received a
Siteman Cancer Center
Development Project grant
of $20,000 for research on
"Site-specific stealth molecular beacons for imaging
cathepsin D expression in
tumor cells." Schotland and
Achilefu, as principal
investigators, received a
Washington University
Molecular Imaging Center
Pilot Research Award of
$19,714 for research on
"Receptor-specific Tatpeptide conjugates."
Jeffrey Bradley, MD, assistant professor of radiation
oncology, received a oneyear Barnes Research
Development Award of
$15,250 to study FDG-PET
registration with treatment
planning CT scans.
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David Gierada, MD, assistant professor of radiology,
received a $12.4 million
contract from the National
Cancer Institute for the
National Lung Screening
Trial (NLST), which will
measure lung cancer detection rates of single-view X
ray as compared to spiral
computed tomography. The
Mallinckrodt Institute contract is part of a larger
Washington University contract coordinated by Gerald
Andriole, MD, who is head of
the preventive cancer
research organization PLCO
(prostate, lung, colon, and
ovarian). Andriole is principal investigator for PLCO
and for NLST; Gierada is
NLST leader and co-principal
investigator.
Bonnie Joe, MD, PhD,
clinical fellow in magnetic
resonance imaging, received
a Radiological Society of
North America Fellowship
grant of $50,000 for research
on "Evaluation of MR contrast enhancement and MRS
in breast cancer: effect of
contrast injection rate and
effect of contrast on MRS
profile."
Mark Mintun, MD, professor of radiology, as principal
investigator, received a
$200,000 grant from the
National Institutes of Health
for research on "Nicotineinduced dopamine changes
in addicted smokers."

Bruce Whiting, PhD,
research assistant professor
of radiology, as principal
investigator, received a
$382,813 grant from the
National Cancer Institute for
research on "Radiation dose
reduction in X-ray computed
tomography." Coinvestigators for the two-year grant
are Kyongtae Bae, MD,
PhD, assistant professor of
radiology; Steven Don, MD,
assistant professor of radiology; Charles Hildebolt,
DDS, PhD, associate professor of radiology; and
Benjamin Lee, MD, associate professor of radiology.
Jie Zheng, PhD, research
assistant professor in radiology, as principal investigator, received a $121,000
grant from the American
Heart Association (Heartland
Affiliate) for research on
"Myocardial flow reserve
measurement by magnetic
resonance imaging: a BOLD
approach." Coinvestigators
are Robert J. Gropler, MD,
associate professor of radiology, of medicine, and of
biomedical engineering;
Dmitriy Yablonskiy, PhD,
assistant professor of
radiology; Dana
Abendschein, PhD,
Department of Internal
Medicine; Pamela
Woodard, MD, assistant
professor of radiology;
Debiao Li, PhD,
Northwestern University.

APPOINTMENTS/
ELECTIONS
Colin Derdeyn, MD, associate professor of radiology,
was elected to a one-year
term as chair of the
Nominating Committee of
the American Society of
Interventional and
Therapeutic Neuroradiology
and was appointed to a oneyear term on the Society's
Executive Committee. He
was appointed to a two-year
term on the Research
Committee of the American
Society of Neuroradiology
and to a two-year term on
the Membership/Credentials
Committee of the American
Heart Association Stroke
Council.
Dione Farria, MD, MPH,
assistant professor of radiology, was appointed chair
of the American College
of Preventive Medicine
Mentorship Program, Young
Physician's Section. She was
appointed adjunct assistant
professor of community
health, Saint Louis
University School of Public
Health, St. Louis, Missouri.
Louis Gilula, MD, professor of radiology and of
surgery, was appointed as an
musculoskeletal examiner
for the American Board of
Radiology's oral boards held
in Louisville, Kentucky,
June 9-12.
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Robert Malyapa, MD, PhD,
radiation oncology chief resident, received an American
Brachytherapy Society
(ABS) Travel Award to
attend the ABS 2002 Annual
Meeting in Orlando, Florida,
May 22-24.

Jay Heiken, MD, professor
of radiology, chief of
abdominal imaging, and
codirector of body computed
tomography, was appointed
moderator of the plenary
session on "Abdominal MRI"
and as a member of the
Unknown Film Reading
Panel for the Abdominal
Radiology Course 2002. The
meeting, which was sponsored by the Society of
Gastrointestinal Radiologists
and the European Society of
Gastrointestinal and
Abdominal Radiology, was
held in Orlando, Florida,
April 14-19.
Robert McKinstry, MD,
PhD, assistant professor of
radiology, was appointed as
a member of the National
Institutes of Health Study
Section, Center for Scientific
Review, Special Emphasis
Panel for Innovations in
Pediatric Neuroimaging. He
was appointed to the editorial board of the journal Neurology. McKinstry recently
completed a one-year term
as chair of the Steering
Committee for a multicenter
study, "The MRI study of
normal brain development."
Eduardo Moros, PhD,
associate professor of radiation oncology, was elected to
a one-year term as vice
president-elect of the North
American Hyperthermia
Society.

LECTURES/
PRESENTATIONS
Samuel Achilefu, PhD,
associate professor of
radiology, as guest speaker,
presented "The role of
exogenous contrast agents in
optical imaging of tumors
and organ function
monitoring" at the The
Speed School of Engineering
Seminar Series, University
of Louisville, Kentucky,
April 12.

Jeffrey Bradley, MD,
assistant professor of radiation oncology, spoke on
"Image-guided radiotherapy
utilizing PET fusion in lung
carcinoma: a window toward
the future" at the State
University of New York,
Stony Brook, June 5.

Carmen Dence, MS,
research scientist of
radiology, presented "[C-ll]
tracers to quantify myocardial metabolism with PET" at
the University of Cambridge,
Wolfson Brain Imaging
Center, Cambridge, England,
May 30.

Jeffrey Brown, MD, associate professor of radiology,
presented "Abdominal MRA"
at the Tenth Scientific
Meeting and Exhibition of
the International Society for
Magnetic Resonance in
Medicine, Honolulu, Hawaii,
May 18-24.

Colin Derdeyn, MD, associate professor of radiology,
spoke on "The carotid
occlusion surgery study" and
"Carotid angioplasty and
stenting" at the Missouri
Society of Radiologic
Technologists Annual
Meeting, Lake of the Ozarks,
Missouri, April 18. He presented the plenary lecture
"Acute stroke intervention"
at the American Society of
Neuroradiology Annual
Meeting, Vancouver, Canada,
May 14.

Mickey Clarke, CNMT,
division administration, Division of Nuclear Medicine,
presented "Current status of
nuclear medicine technology
in the United States," at the
22nd Annual Meeting of the
Japanese Society of Nuclear
Medicine Technology,
Osaka, Japan, July 27 and 28.

Radiation
Oncology
Residents
2001-2002

i

(Left to right) Doctors
Charles Hechtman;
Anurag Singh; Gregg
Franklin; Jon Anders;
Fengming Kong; Jeff
Michalski, director,
Clinical Division; Ana Botero, radiation oncology chief resident; Jeffrey Bradley,
director, Radiation Oncology Residency Program; Robert Malyapa, radiation oncology
assistant chief resident; Wayne Lamoreaux.
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Louis Gilula, MD,
professor of radiology and
of surgery, presented
"Analysis of complex carpal
trauma" at the San Francisco
Bay Area Hand Society
meeting, San Francisco,
California, May 10.
Perry Grigsby, MD, professor of radiation oncology
and of radiology, presented
"Neoadjuvant chemotherapy
and surgery versus standard
radiotherapy for locally
advanced cervix cancer. A
meta-analysis using individlal patient data from
•andomized controlled trials
(RCTs)" at the 2nd
iternational Conference on
Cervical Cancer, M. D.
Anderson Cancer Center,
University of Texas,
Houston, April 11-14. He
spoke on "Place of
chemotherapy in locally
advanced bulky cervical
:enters," "Place of radiotherapy in surgically staged
endometrial cancers," "Place
of radiotherapy in ovarian
cancers" at the 8th Annual
Meeting of Turkish
Gynecologic Oncology
Society, Antalya, Turkey,
May 1-5.
William Harms, BS,
instructor in radiation oncology, spoke on "Technical
requirements for participating in advanced technology
radiation oncology clinical
trials" at the Radiation
Therapy Oncology Group
semiannual meeting,
Philadelphia, Pennsylvania,
June 13.
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Jay Heiken, MD, professor
of radiology, chief of abdominal imaging, and codirector
of body computed tomography, spoke on "CT evaluation of pancreatic arcinoma"
at the Abdominal Radiology
Course 2002, sponsored
by the society of Gastrointestinal Radiologists and the
European Society of Gastrointestinal and Abdominal
Radiology, Orlando, Florida,
April 14-19. As visiting
professor, he presented "CT
colonography: technique,
results, issues;" "Multi-slice
CT: principles and applications in the abdomen;" and
"Characterization of hepatic
masses with CT and MRI" at
the University of Ottawa,
Canada, May 30-31. Heiken
presented "New concepts for
optimizing contrast medium
delivery"at the 4th
International Symposium on
Multidetector-Row CT,
sponsored by Stanford
University, San Francisco,
California, June 20-23.
Robert Malyapa, MD, PhD,
radiation oncology chief
resident, presented
"Improved brachytherapy
treatment planning using
positron emission tomography (PET) for cervical
cancer" at the 23rd
American Brachytherapy
Society Meeting, Orlando,
Florida, May 22-24.

Elizabeth McFarland, MD,
associate professor of radiology, presented "Patient
appraisals of CT colonography, conventional
colonoscopy, and the bowel
preparation" and served as
moderator for "Diagnostic
performance of CT colonography" at the Third International Symposium of Virtual
Colonoscopy, Boston,
Massachusetts, April 8-10.
She spoke on "CTA: pre and
post operative evaluation of
endovascular stent grafts;"
CT colonography;" and
"Evolving 3D CT body applications" at the Oklahoma
State Radiological Society
Meeting, Tulsa, April 19 and
20. McFarland presented
"Prospective study of CT
colonography (air vs. C02
insufflation techniques) and
colonoscopy: assessments of
procedure times and image
quality" at the Society of
Gastrointestinal Radiology
meeting, Orlando, Florida,
April 14.

Robert McKinstry, MD,
PhD, assistant professor of
radiology, spoke on "Diffusion tensor MR imaging in
neuroradiology" at
Radiology Grand Rounds,
Medical College of Georgia,
Augusta, April 19, and
Radiology Grand Rounds,
Northwestern University
Medical center, Chicago,
Illinois, June 12. He spoke on
"MR imaging of normal brain
maturation" at the Radiology
Department, Tripler Army
Medical Center, Honolulu,
Hawaii, May 21. He presented "Introduction to diffusion imaging," "Diffusion
imaging and stroke evolution," "Diffusion imaging pitfalls," and "Cranial nerves" at
World Class MR and CT:
Achieving Excellence in
Neuro/Skeletal Imaging Conference, Minneapolis, Minnesota, July 7.
Jeff Michalski, MD, associate professor of radiation
oncology and director of the
Clinical Division, presented
"Medical updates in oncology practice: prostate cancer: research & practice
update" at the First Annual
Siteman Oncology Nursing
Symposium 2002, St. Louis,
Missouri, April 5. He presented "Conformal RT: the
USA view; U.S. clinical trials
of 3D CRT for prostate cancer" at the MRC RT01
Participants Meeting,
London, England, April 26.
Michalski spoke on "Clinical
trials on 3D conformal radiation therapy" at the Quebec
Association of Radiation
Oncologists meeting, TroisRivieres, Canada, June 9.
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Tom Miller, MD, PhD,
professor of radiology and
of biomedical engineering,
spoke on "PET in cervical
cancer and prostate cancer"
at the 5th International
Congress of Nuclear
Oncology, Kusadasi, Turkey,
May 1-3.
Eduardo Moros, PhD,
associate professor of radiation oncology, presented
"Thermoradiotherapy engineering research, development and support" to the
Department of Mechanical
Engineering, University of
Maryland, Baltimore, May 3.
Nobuyuki Oyama, MD,
PhD, visiting assistant professor in radiology, presented "Diagnosis of
recurrent prostate cancer
using HC-acetate PET" at
the 90th Annual Meeting of
the Japanese Urological
Association, Tokyo, Japan,
April 19. He spoke on
"Carbon-11-acetate PET
imaging of recurrent
prostate cancer" at the 97th
Annual Meeting of the
American Urological
Association, Orlando,
Florida, May 26.

Carlos Perez, MD, professor of radiation oncology
and chair of the Department
of Radiation Oncology,
spoke on "Prostate cancer:
state of the art" at the 2nd
International Prostate
Cancer Congress,
St. Thomas, U.S. Virgin
Islands, July 17. He presented "Breast conserving
therapy in Tl and T2 tumors"
and "Radiation therapy in
locally advanced breast
cancer" at the First
Interamerican Breast Cancer
Conference, Cancun,
Mexico, July 27. Perez presented "Radiation for
prostate cancer: state of the
art" and "Hormone and radiation therapy in localizes
prostate cancer" at the
AstraZeneca Regional
Urology Advisory Board,
Mackinac Island, Michigan,
August 1 and 2.
David Piwnica-Worms,
MD, PhD, professor of radiology and of molecular biology and pharmacology and
director of the Molecular
Imaging Center, presented
"Strategies and development
of radiopharmaceuticals for
assessment of MDR and gene
therapy" at the 7th Annual
Oncology Conference:
Targeted Diagnostics and
Therapy and the 2nd Annual
Scientific Session: CancerSpecific Radiopharmaceuticals, St. Louis, Missouri,
April 19-21.

Joseph Roti Roti, PhD,
professor of radiology and
chief of the Division of
Radiation and Cancer
Biology, presented "The
effect of chronic exposure to
835.62 MHz FMCW or 847.74
CMDA on the incidence of
spontaneous tumors in rats"
at the 24th Annual Meeting
of the Bioelectromagnetics
Society, Quebec City,
Canada, June 23-27.
Stuart Sagel, MD, professor of radiology, chief of
chest radiology, and codirector of body computed
tomography, presented "CT
of the thoracic aorta" and
"Unknown cases" at the
Annual Conference on Chest
Disease of the Fleischner
Society, Brugge, Belgium,
May 12-16.
Maria Schmidt, MD, assistant professor of radiology,
spoke on "Breast imaging
and management guidelines"
at Cancer of the Breast:
Current Trends and Future
Progress, St. Louis, Missouri,
May 11.
Joshua Shimony, MD,
PhD, instructor in radiology,
spoke on "Automated fuzzy
clustering of neuronal pathways in diffusion tensor
tracking" at the Tenth Scientific Meeting and Exhibition
of the International Society
for Magnetic Resonance in
Medicine, Honolulu, Hawaii,
May 18-24.

Barry Siegel, MD, professor of radiology and of medicine and director of the
Division of Nuclear
Medicine, presented
"Applications of FDG-PET in
oncology" at the 7th Annual
Oncology Conference:
Targeted Diagnostics and
Therapy and the 2nd Annual
Scientific Session: CancerSpecific Radiopharmaceuticals, St. Louis, Missouri,
April 19-21. He presented
"PET scanning of cancer:
current indications" and
served on discussion panels
for Thoracic Tumors, and
ENT Tumors at The 2002
San Francisco Conference:
Radiation Oncology, San
Francisco, California, April
19-21. He presented "PET:
patient preparation, interpretation pitfalls and reimbursement issues" and "PET in
oncology II" and served on
the PET Case Review and
Expert Panel at the 26th
Annual Course of Clinical
Nuclear Medicine, Cambridge, Massachusetts,
April 29-May 2. Siegel spoke
on "PET oncology
overview," "PET evaluation
of esophageal carcinoma,"
"PET oncology beyond
FDG," and "PET in gynecologic neoplasms" at P.E.T. &
Nuclear Cardiology in
Dublin, Ireland, July 21-26.
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Marilyn Siegel, MD, professor of radiology and of
pediatrics, spoke on "Fast
MRI of small cell tumors in
children: an NCI protocol" at
the Children's Oncology
Group Meeting, Jacksonville,
lorida, April 16, and at the
Society of Pediatric
Radiology, Philadelphia,
Pennsylvania, April 30. As
visiting professor, she presented "CT/MR of the liver:
techniques and indications;"
"CT/MR of retroperitoneal
neoplasms: diagnosis and
staging;" "Hemorrhagic/
ischemic brain injury in
infants;" "Ultrasonography of
neonatal renal diseases;"
"MDCT of the airway;" and
"Thymic CT in Children" at
Kwong Wah Hospital, Hong
Kong, June 17-21. Siegel
spoke on "Sonography and
CT of acute abdominal pain
in children" at the Hong
Kong Radiological Society,
Hong Kong, June 17.
Michael Welch, PhD, professor of radiology and of
chemistry and codirector of
the Division of Radiological
Sciences, presented "Design
and use of PET radiopharmaceuticals (other than
FDG) for cancer diagnosis
and therapy" at the 7th
Annual Oncology Conference: Targeted Diagnostics
and Therapy and the 2nd
Annual Scientific Session:
Cancer-Specific Radiopharmaceuticals, St. Louis, Missouri, April 19-21. As invited
speaker, he presented "New
radioisotopes for PET" and
"Myocardial metabolic imaging using l-[ll-C]-D-glucose,
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l-[ll-C]-palmitate and 1-[11C]-acetate" at the Turku PET
Symposium, Turku, Finland,
May 25-28.

Eduardo Moros, PhD,
cochair, Non-Invasive
Treatment Monitoring and
Treatment Planning.

Dmitriy Yablonskiy, PhD,
assistant professor of radiology, presented "What 3He
diffusion can tell about lung
microstructure," "On the role
of blood flow in brain temperature regulation," and
"Microstructure of human
lung as revealed by hyperpolarized 3He diffusion MRI" at
the Tenth Scientific Meeting
and Exhibition of the
International Society for
Magnetic Resonance in
Medicine, Honolulu, Hawaii,
May 18-24.

Joseph Roti Roti, PhD,
chair, NAHS Hyperthermia
and Radiation Sensitivity;
cochair, NAHS Defining
Thermal Goals for
Hyperthermia.

SYMPOSIA
In this section ofFYI, only
those faculty and staff
who have Department of
Radiology or Department
of Radiation Oncology
appointments are listed.

RADIATION
RESEARCH SOCIETY
and
NORTH AMERICAN
HYPERTHERMIA SOCIETY
Annual Scientific Meeting
Reno, Nevada
Apri\ 20-24, 2002

POSTER SESSIONS
Robert VanderWaal, PhD;
Beth Pierburg; Joseph
Roti Roti, PhD, "Redox
sensitive protein(s) are
involved with anchoring
DNA to the nuclear matrix."
Mai Xu, MD, PhD; Robert
Myerson, MD, PhD;
Eduardo Moros, PhD;
Clayton Hunt, PhD;
William Straube, MS;
Joseph Roti Roti, PhD,
"DNA-dependent protein
jinase regulates Werner
syndrome protein linking
aging to DNA repair."

SCIENTIFIC SYMPOSIA
Clayton Hunt, PhD,
"HSP70 is not required for
normal mouse development,
viability, or fertility."
Eduardo Moros, PhD; Petr
Novak, MSc; William
Straube, MS; Robert
Myerson, MD, PhD, "The
making of a clinical
SURLAS: finalizing the scanning reflector mechanism."

Eduardo Moros, PhD; Mai
Xu, MD, PhD; William
Straube, MS; Joseph Roti
Roti, PhD, "Dynamics of
cell culture media temperature inside flasks kept in
laboratory incubators."
Robert Myerson, MD,
PhD; Heather Bigott;
John Engelbach; Jason
Lewis, PhD; Deborah
McCarthy, PhD; Terry
Sharp; Joonyoung Kim,
PhD; Michael Welch, PhD,
"Monitoring the effect of
mild hyperthermia on
tumor hypoxia by Cu-ATSM
PET scanning: preliminary
studies."
Petr Novak, MSc, "A novel
ultrasonic method for
non-invasive temperature
monitoring during
microwave thermotherapy."
William Straube, MS;
Eduardo Moros, PhD,
"In vitro measurement and
analysis of backscattered
ultrasound and its change
with temperature."
William Straube, MS;
Eduardo Moros, PhD,
"Noninvasive temperature
estimation based on energy
of backscattered ultrasound."
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Ultrasound
William Middleton, MD,
"US evaluation of portal
hypertension."

AMERICAN ROENTGEN
RAY SOCIETY

Sharlene Teefey, MD,
"US evaluation of TIPS."

102nd Annual Meeting
Atlanta, Georgia
April 28-May 3, 2002

New Issues Forum

RESIDENT TUTORIAL

William Middleton, MD,
"Sonography of the shoulder."

Marilyn Siegel, MD, "CT
and US of the acute pediatric
abdomen."

Sharlene Teefey, MD,
"Sonography of the wrist."

CATEGORICAL COURSE BODY CT
Dennis Balfe, MD, "CT of
the biliary tree."

John Leyendecker, MD;
Elizabeth McFarland, MD;
Dennis Balfe, MD,
"Colorectal polyp screening
techniques: current status
and panel discussion of barium enema, colonoscopy,
CT colonography, and MR
colonography."

Jay Heiken, MD, "CT of
small bowel obstruction."
Marilyn Siegel, MD,
"Pediatric CT: practice
guidelines."
INSTRUCTIONAL COURSES

Master Tutorial
Marilyn Siegel, MD,
"Imaging of the acute pediatric abdomen."
Pediatrics: CT and MRI —
Imaging of the Pediatric
Mediastinum
Sanjeev Bhalla, MD,
"Nonvascular lesions."
Fernando Gutierrez, MD,
"Vascular lesions."

Pediatric Genitourinary Tract
Marilyn Siegel, MD,
"Renal masses."

SCIENTIFIC EXHIBITS

NINTH INTERNATIONAL
WORKSHOP ON
TARGETRY AND TARGET
CHEMISTRY
Turku, Finland
May 23-25, 2002

SCIENTIFIC SESSIONS
Reports from the Laboratories
Carmen Dence, MS;
William Margenau;
Christopher Bognar;
Stephen Moerlein, PhD;
Mohammed Al-Qahtani,
PhD; Michael Welch, PhD,
"GE PETtrace MEI
MICROLAB: six years'
experience with system."

Gregory Gaehle; Sally
Schwarz, MS, RPh;
Michael Mueller; Michael
Welch, PhD, "The installation of a multi-radiopharmaceutical PET facility at
Washington University in
St. Louis, MO, USA."
Deborah McCarthy, PhD;
Heather Bigott; Douglas
Rowland, PhD; Todd
Perkins; Thomas Voller;
Richard Laforest, PhD;
David Reichert, PhD;
Michael Welch, PhD,
"A research resource in
radionuclide research."

Other topics: Radiochemistry
and Automation
Douglas Rowland, PhD;
Richard Laforest, PhD;
Michael Welch, PhD, "The
present status of a high
current inclined target and
solid target changer at
Washington University."
Sally Schwarz, MS, RPh;
Keith Lechner; Michael
Mueller; Gregory Gaehle;
Michael Welch, PhD,
"Radiopharmaceutical production quality control
considerations."
Lucie Tang; David
Reichert, PhD; Deborah
McCarthy, PhD; Michael
Welch, PhD, "Remote and
automated solvent extraction of gallium-66."
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49th Annual Meeting
Los Angeles, California
June 15-19, 2002
!

Tom Miller, MD, PhD,
chair, Scientific Program.

'{

Sally Schwarz, MS, RPh,
comoderator, Radiopharmaceutical Chemistry Track—
Radiopharmacy II:
Radiopharmaceuticals.

\
I
1

Michael Welch, PhD, vice
chair, Radiopharmaceutical
Chemistry Track: New
Chemistry—Oncology; New
Chemistry—Neurosciences;
New Chemistry—Other;
Radiopharmacy;
Dosimetry/Radiobiology.

)

CATEGORICAL SEMINAR
Jason Lewis, PhD,
"Cyclotron-produced
radionuclides for cancer
therapy."
CONTINUING EDUCATION
COURSE
Yuan-Chuan Tai, PhD;
Michael Welch, PhD,
"Instruments and radiophai
maceuticals needed for
modern molecular imaging
techniques."

SCIENTIFIC SESSIONS
Pilar Herrero, MS; Donna
Cassady, RN; Zulfa
Kisrieva-Ware, MD, PhD;
Robert Gropler, MD,
"Myocardial fatty acid oxid
tion is increased in patient'
with insulin dependent
diabetes mellitus."
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Jason Lewis, PhD; YunI peng Ye, PhD; Joonyoung
Kim, PhD; John EngelIbach; Richard Laforest,
|PhD; Michael Welch, PhD,
tratumoral administration
ofCu-64-ATSMorCu-61VTSM: therapeutic comparison in GW39 tumors."

Jeongsoo Yoo, PhD; David
Reichert, PhD; Joonyoung
Kim, PhD; Carolyn
Anderson, PhD; Michael
Welch, PhD, "A lipophilic
D03A-based cyclen complex
of wCu: synthesis, biodistribution study and microPET
imaging."

en Ping Li, PhD; Jason
ewis, PhD; Joonyoung
Kim, PhD; Carolyn Anderson, PhD, "New somatostatin analog for
radiolabeling with metals
and halogens: wCu/61 and
ls
I-labeled DOTA-DTyrl-octreotate."
Ty

Xiankai Sun, PhD;
Joonyoung Kim, PhD;
Michael Welch, PhD; Carolyn Anderson, PhD,
"Potential bone-imaging
agent: 64Cu-labeled 1,4,7,
10-tetraazacyclododecane1,4,7-tri(methanephosphonic
acid)."

Wieng

Ping Li, PhD; Jason
Lewis, PhD; Carolyn
Anderson, PhD, "64CuDOTA-CTTHWGFTLC, a
I selective gelatinase inhibitor
for tumor imaging."
,
,
|
i
i
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Tom Miller, MD, PhD;
Perry Grigsby, MD,
"Improved prognostic value
of FDG-PET in patients with
cervical cancer using a simpie visual analysis of tumor
characteristics."

Nobuyuki Oyama, MD,
PhD; Datta Ponde, PhD;
Joonyoung Kim, PhD;
• John Engelbach; Nicole
Mercer; Lynne Jones;
Terry Sharp; Michael
Welch, PhD, "MicroPET
imaging of prostate cancer
using 18F-FLT: androgen
dependent tumor model
study."

POSTER SESSIONS
MohammedAl-Qahtani;
Michael Welch, PhD,
"Radiosynthesis of 18F-fluoropropylpyrazoletriphenol, a
new ligand selective for the
estrogen receptor."
Joonyoung Kim, PhD;
Robert Myerson, MD,
PhD; Heather Bigott; Pilar
Herrero, MS; Terry Sharp;
Jason Lewis, PhD; Michael
Welch, PhD, "Quantitative
analysis of wCu-ATSM kinetics in an animal tumor
model."
Deborah McCarthy, PhD;
Michael Welch, PhD,
"Production of therapeutic
M
Cu radionuclide, using a
ultra-small cyclotron."

Stephen Moerlein, PhD;
Joel Perlmutter, MD;
Joonyoung Earn, PhD;
John Engelbach; Lynne
Jones; Nicole Mercer;
Richard Laforest, PhD;
Michael Welch, PhD,
"MicroPET imaging of neuroreceptor binding in rodent
brain: comparison with ex
vivo measurements."
Peter Wolohan, PhD;
David Reichert, PhD,
"Comfa and docking study of
novel estrogen receptor
subtype selective ligands."

AMERICAN ASSOCIATION
OF PHYSICISTS IN
MEDICINE
44th Annual Meeting
Montreal, Canada
July 14-18, 2002
Joseph Deasy, PhD,
cochair, Radiobiology
Scientific Session.
Eric Klein, MS, recipient of
the 2002 AAPM-IPEM
Medical Physicals Travel
Grant; cochair, Treatment
Techniques and Delivery
Systems Scientific Session.
Zuofeng Li, DSc, cochair,
IMRT Delivery 2 Scientific
Session.
Daniel Low, PhD, cochair,
IMRT Validation/Verification
2 Scientific Session.
Eduardo Moros, PhD,
cochair, Therapy—Other
Scientific Session.
Sasa Mutic, MS, cochair,
Improvements in Conventional Planning Scientific
Session.
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Jason Sohn, PhD, cochair,
Therapy Poster Session:
Image-guided Therapy
Imaging Techniques and
Tools; Particle Based
Radiation Therapy;
Radiobiology; Stereotactic.

CONTINUING EDUCATION
COURSES
Daniel Low, PhD, "Clinical
issues for IMRT4: measurement and analysis techniques for IMRT;"
"Measurement and analysis
techniques for IMRT."
Sasa Mutic, MS, "Imaging
radiation oncology: use of
CT and PET in radiation
therapy;" "Use of CT and
PET in radiation therapy."

POSTER SESSIONS
Joseph Deasy, PhD,
"CERR: a computational
environment for radiotherapy research."
Joseph Deasy, PhD;
Konstantin Zakaryan,
PhD, "A prototype Monte
Carlo-based IMRT treatment
planning research system."
Joseph Deasy, PhD;
Daniel Low, PhD, "Dose
volume projections."
Joseph Deasy, PhD, "An
efficient relaxation method
for dose-volume constraints
in IMRT."
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Robert Drzymala, PhD;
ZuofengLi, DSc; Eric
Klein, MS, "In vivo diode
dosimetry and backscatter."
Eric Klein, MS, "Head
scatter and surface/buildup
dose characteristics for 6, 10,
and 18 MV photons from am
Elekta Precise accelerator."
Fengming Kong, MD; Jose
Garcia-Ramirez, MS; Eric
Klein, MS, "A new treatment technique to irradiate
internal mammary nodes in
breast cancer."
Daniel Low, PhD, "Gel
dosimetry by MRI using 3D
gradient echo sequences."
Daniel Low, PhD; Sasa
Mutic, MS; Tom Miller,
MD, PhD; Jeffrey
Williamson, PhD; Perry
Grigsby, MD, "Can IMRT
replace intracavitary
brachytherapy?"
Robert Malyapa, MD, PhD;
Sasa Mutic, MS; Daniel
Low, PhD; Imran Zoberi,
MD; Walter Bosch, DSc;
Tom Miller, MD, PhD;
Perry Grigsby, MD,
"FDG-PET guided dose
optimization in HDR
brachytherapy for treatment
of cervical cancer."

Sasa Mutic, MS; Robert
Malyapa, MD, PhD; Perry
Grigsby, MD; Imran
Zoberi, MD; Daniel Low,
PhD, "Treatment planning
guidelines regarding the use
of CT/PET-guided IMRT for
carcinoma of the cervix with
para-aortic lymph node
involvement."
Jason Sohn, PhD, "Comparison of measurements
with radiochromic films and
Monte Carlo simulation for
small beams in heterogeneous phantoms."
Jeffrey Williamson, PhD;
Zuofeng Li, DSc, "Thermoluminescent dosimetry of a
new type of 1-125 seed,
SourceTech Medical model
STM1251."

SCIENTIFIC SESSIONS
Imad Ali, PhD; Corneliu
Costescu, PhD; Milos
Vicic, PhD; Jeffrey
Williamson, PhD, "Dependence of radiochromic film
optical density post-exposure darkening kinetics on
dose and dose fractionation."
Corneliu Costescu, PhD;
Jeffrey Williamson, PhD;
Milos Vicic, PhD, "On the
influence of the photon scattering model on Monte Carlo
simulation of low energy
photon brachytherapy dose
distributions."

Zuofeng Li, DSc; Eric
Klein, MS; Robert
Drzymala, PhD; James
Purdy, PhD, "Photoneutron
dose levels in a linear
accelerator room with lead
shielding."
Daniel Low, PhD; Jeffrey
Bradley, MD; David
Politte, DSc; Sasa Mutic,
MS; Joseph Deasy, PhD,
"4D (time-dependent)
measurements of breathing
motion using multislice CT
scanning."
Robert Malyapa, MD, PhD;
Sasa Mutic, MS; Perry
Grigsby, MD; Walter
Bosch, DSc; Imran Zoberi,
MD; Farrokh Dehdashti,
MD; Tom Miller, MD, PhD;
Daniel Low, PhD, "PETguided-IMRT treatment for
cervical carcinoma with
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